OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Vaxxas recognised as Janssen Ausbiotech Emergeing Company of the Year 2012

 
Read more
 
AwardsCarolyn MillerOctober 31, 2012Vaxxas, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Hatchtech publish data on Head Lice treatment safety study and mechanism of action

Media ReleaseCarolyn MillerNovember 27, 2012Hatchtech, Paul Kelly
Next

Novel Pediculicide Clears Most Head Lice With 1 Application

MedscapeCarolyn MillerOctober 25, 2012Hatchtech, Paul Kelly

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd